About Luye Pharma
Luye Pharma is a company based in Shanghai (China) founded in 1994. It operates as a Direct-to-Consumer (D2C). The company has 5,150 employees as of December 31, 2024. Luye Pharma has completed 1 acquisition, including A-Bio Pharma. Luye Pharma offers products and services including Ruoxinlin®, LY03021, and Rykindo®.
- Headquarter Shanghai, China
- Employees 5150 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Luye Pharma Group Ltd.
-
Annual Revenue
$845.94 M (USD)-3.18as on Dec 31, 2024
-
Net Profit
$65.88 M (USD)-13.07as on Dec 31, 2024
-
EBITDA
$271.68 M (USD)17.77as on Dec 31, 2024
-
Latest Funding Round
$161.21 M (USD), Post-IPO
Jan 31, 2021
-
Investors
Hillhouse
& 1 more
-
Employee Count
5150
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Luye Pharma
Luye Pharma is a publicly listed company on the HKEX with ticker symbol 2186 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Luye Pharma
Luye Pharma offers a comprehensive portfolio of products and services, including Ruoxinlin®, LY03021, and Rykindo®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Innovative drug used for depression and anxiety treatment.
Innovative antidepressant drug under clinical research phase.
Innovative drug launched for international market access.
Funding Insights of Luye Pharma
- Total Funding Total Funding
- Total Rounds 2
- Last Round Post-IPO — $161.2M
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2021 | Amount | Post-IPO - Luye Pharma | Valuation |
investors |
|
| Mar, 2012 | Amount | Private Equity Round - Luye Pharma | Valuation | Ardian |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Luye Pharma
Luye Pharma has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Hillhouse and Ardian. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Global private equity investments are managed with long-term focus.
|
Founded Year | Domain | Location | |
|
Private investment firm specializing in markets and partnerships.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Luye Pharma
Luye Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include A-Bio Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Mammalian cell-line development services are provided for biopharmaceutical needs.
|
2002 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Luye Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Luye Pharma Comparisons
Competitors of Luye Pharma
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Luye Pharma
Frequently Asked Questions about Luye Pharma
When was Luye Pharma founded?
Luye Pharma was founded in 1994 and raised its 1st funding round 18 years after it was founded.
Where is Luye Pharma located?
Luye Pharma is headquartered in Shanghai, China.
How many employees does Luye Pharma have?
As of Dec 31, 2024, the latest employee count at Luye Pharma is 5,150.
What is the annual revenue of Luye Pharma?
Annual revenue of Luye Pharma is $845.94M as on Dec 31, 2024.
What does Luye Pharma do?
Luye Pharma Group Ltd. is involved in the research, development, production, and sales of innovative pharmaceuticals. The company operates internationally, focusing on therapeutic areas such as depression and anxiety disorders. Solutions are provided through products like Ruoxinlin and Rykindo, targeting global healthcare markets. The group serves various sectors within the pharmaceutical industry, emphasizing innovation and clinical advancements.
What products or services does Luye Pharma offer?
Luye Pharma offers Ruoxinlin®, LY03021, and Rykindo®.
Is Luye Pharma publicly traded?
Yes, Luye Pharma is publicly traded on HKEX under the ticker symbol 2186.
How many acquisitions has Luye Pharma made?
Luye Pharma has made 1 acquisition, including A-Bio Pharma.
Who are Luye Pharma's investors?
What is Luye Pharma's ticker symbol?
The ticker symbol of Luye Pharma is 2186 on HKEX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.